CTSE and prostate carcinoma: In human prostate-cancer cell lines, a higher expression of CTSE induces growth arrest and apoptosis by catalyzing the proteolytic release of a tumor necrosis factor-related apoptosis-inducing ligand, which induces apoptosis [41].